Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell Carcinoma
Clinical trial NCT02218164 · COMPLETED
Trial details
- NCT number
- NCT02218164
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-12
- Primary completion
- 2017-07-19
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.